Best Pharmaceuticals for Children Act (BPCA) Activities at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Implementation and coordination of the BPCA activities is a major activity for the NICHD’s Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB). The goal of the BPCA Program is to improve pediatric therapeutics through preclinical and clinical drug trials that lead to drug labeling changes.

The OPPTB is also responsible for developing and supporting a comprehensive national research and training effort to increase the knowledge base for treating diseases in pregnant women, infants, and children, using drugs that are appropriately tested within these target populations. 


2014 BPCA Annual Meeting
December 10, 2014
Natcher Conference Center, Bethesda, MD and via Webinar
Meeting Summary (PDF 202 kb)

*NEW: NICHD-Funded Research Finds Biological Basis for Children’s Taste (PDF 333 kb)

A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms (PDF 474 kb)

Learn about the new Pediatric Formulations Platform initiative funded through an inter-agency agreement between the NICHD and the FDA.

Check out the new FDA Office of Pediatric Therapeutics Web site.